Astrazeneca ADR Stock
Price
Target price
€63.50
€63.50
0.000%
-
0.000%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Astrazeneca ADR Stock
There is no change in the price for Astrazeneca ADR today.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Astrazeneca ADR stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Astrazeneca ADR in the next few years
Pros
?
S********** s********
?
M***** P*******
?
B****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Astrazeneca ADR vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Astrazeneca ADR | 0.000% | 0.794% | -1.550% | -12.414% | -0.781% | 3.420% | - |
GSK plc ADR | 0.000% | 6.471% | 2.841% | -3.723% | 10.366% | -27.600% | -22.979% |
Bayer AG ADR | -4.650% | 2.381% | 8.403% | -6.522% | 30.040% | -60.429% | -59.938% |
Novo Nordisk A/S ADR | 1.760% | 0.322% | 1.961% | -49.880% | -25.359% | -40.571% | 7.586% |
News

3 Promising Growth Stocks You Can Buy for Less Than $100
Investing in growth stocks is a great way to grow your portfolio in the long run. But it can be difficult to predict which ones will take off in value and which one's won't. And that's why it might

How Does D-Wave Stack Up Against Quantum Competitors?
[content-module:CompanyOverview|NYSE:QBTS]
D-Wave Quantum Inc. (NYSE: QBTS) has emerged as one of the most talked-about stocks in the quantum computing industry, a space investors are watching

Tempus AI Stock: Time to Double Down or Cut and Run?
[content-module:CompanyOverview|NASDAQ:TEM]
Tempus AI (NASDAQ: TEM) is an interesting AI story that operates a platform and library for diagnosis and drug discovery. The platform aids physicians